0 code page views remaining today. Guest accounts are limited to 2 daily page views. Register free account to get more views.
Log in Register free account

Official Description

Immune globulin (Ig), human, for intramuscular use

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

Immune globulins are specialized immunizing agents that provide effective, short-term, passive immunity to individuals. This type of immunity is characterized by the presence of antibodies that circulate throughout the body, offering immediate protection against certain infections. Unlike active immunity, where the recipient's immune system is stimulated to produce its own antibodies, passive immunity does not involve this process. Instead, it relies on the administration of human immune globulin, which is a concentrated solution of antibodies derived from the pooled blood of multiple donors. The specific CPT® Code 90281 refers to human immune globulin (Ig) that is administered via intramuscular injection. It is important to note that this code solely represents the product used, and does not encompass any additional procedures or services associated with its administration. For intravenous administration of immune globulin, the corresponding code is 90283.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

Immune globulin (Ig) is indicated for use in various clinical scenarios where passive immunity is required. The following conditions may warrant the administration of immune globulin:

  • Post-exposure prophylaxis for individuals who have been exposed to certain infectious diseases, such as hepatitis A or measles, to prevent the onset of illness.
  • Immunodeficiency disorders in patients who have compromised immune systems, where additional antibodies are necessary to help fight infections.
  • Autoimmune disorders where immune globulin may be used to modulate the immune response and reduce the severity of symptoms.

2. Procedure

The administration of immune globulin (Ig) via intramuscular injection involves several key procedural steps to ensure safety and efficacy. The following outlines the procedure:

  • Step 1: Patient Assessment Before administering immune globulin, a thorough assessment of the patient’s medical history and current health status is conducted. This includes evaluating any previous reactions to immune globulin products and determining the appropriateness of the treatment based on the indications.
  • Step 2: Preparation of the Product The immune globulin product is prepared according to the manufacturer's instructions. This may involve allowing the solution to reach room temperature and gently mixing it to ensure homogeneity. Proper aseptic techniques are employed to maintain sterility during preparation.
  • Step 3: Administration The immune globulin is administered intramuscularly, typically in the deltoid muscle or another suitable site. The injection site is cleaned with an antiseptic solution, and a sterile needle is used to inject the solution. The dosage is determined based on the specific clinical indication and patient factors.
  • Step 4: Monitoring After administration, the patient is monitored for any immediate adverse reactions or side effects. This includes observing for signs of allergic reactions or other complications that may arise from the injection.

3. Post-Procedure

Following the administration of immune globulin, patients are typically advised to rest and may be monitored for a short period to ensure there are no immediate adverse effects. It is important to provide patients with information regarding potential side effects, which may include mild fever, headache, or local reactions at the injection site. Patients should be instructed to report any unusual symptoms or reactions that occur after the procedure. Additionally, follow-up appointments may be scheduled to assess the effectiveness of the treatment and to determine if further doses are necessary based on the clinical situation.

Short Descr HUMAN IG IM
Medium Descr IMMUNE GLOBULIN IG HUMAN IM USE
Long Descr Immune globulin (Ig), human, for intramuscular use
Status Code Not Valid for Medicare Purposes
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Non-Covered Service, not paid under OPPS
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) P6D - Minor procedures - other (non-Medicare fee schedule)
MUE 0
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
Date
Action
Notes
2011-01-01 Changed Short description changed.
1999-01-01 Added First appearance in code book in 1999.
Code
Description
Code
Description
Code
Description
Code
Description